Case Western Reserve University - Technology Transfer Office

?? Exciting Health Tech Innovation! ?? Hemex Health announces the upcoming launch of two new Gazelle product solutions to increase diagnostic accessibility for Iron Deficiency Anemia and Sickle Cell Disease. These affordable, portable tools will help to bring faster, accurate diagnoses to underserved and remote areas, providing critical information to improve access to care. With these advancements, Hemex Health is helping bring advanced diagnostic solutions to the point of care, empowering clinicians to detect and address conditions sooner— for the benefit of at-risk patients in some of the world's most challenging locations. ?? Read more here: https://bit.ly/3AW2ydV #SickleCell #IronDeficiency #Anemia #Diagnostics #HealthTech #GlobalHealth #Innovation

Our ESOGUARD BE-1 study on the EsoGuard? Esophageal DNA Test has been accepted for publication in?The American Journal of Gastroenterology! "The publication of the ESOGUARD BE-1 study, which once again demonstrated unprecedented EsoGuard performance, is a major milestone for Lucid," said?Lishan Aklog, MD, Lucid Diagnostics Chairman and CEO. "With this fourth clinical validation study accepted for peer-reviewed publication, we believe we now have a complete clinical evidence package to submit our data to the MolDX program and formally seek Medicare coverage. We are deeply grateful to Dr. Nick Shaheen and the other investigators, across two continents, for their hard work and commitment to esophageal cancer prevention." Read more: https://lnkd.in/g87eAv_T #CancerPrevention #earlyDetection American College of Gastroenterology

Recognized as Case Western Reserve University's Innovator of the Year in Research, Xiong Yu and his team have made significant strides in advancing smart civil infrastructure over the past year, pushing the boundaries of innovation. “Xiong (Bill) Yu’s group has successfully developed sustainable innovations with great environmental impacts. His vision, mission, and strong partnerships with top-ranked companies have brought the technologies close to the market,” one nominator wrote. Yu received the award at Innovation Week events earlier this week: https://lnkd.in/gNGUAcD7

We are excited to announce we have achieved the first-ever therapeutic #RNAediting in humans in our RestorAATion-2 trial of WVE-006 in Alpha-1 antitrypsin deficiency. Learn more: https://lnkd.in/eVgYjhdx #AATD

"This patent strengthens the already robust intellectual property portfolio underlying our groundbreaking technologies and will provide strong protection for the CCNA1 methylation assay method which is at the heart of the EsoGuard assay," said?Lishan Aklog, MD, Lucid Diagnostics Chairman and Chief Executive Officer. Read more here: https://lnkd.in/gPfrPJF7

BIOHM Health, Inc. is thrilled to unveil our new corporate brand identity, Biohm Technologies, reflecting the company’s redefined strategy focused on B2B solutions in the nutraceutical industry. Our updated name, coupled with a fresh look and feel, represents our commitment to the advancement of microbiome innovation for the greater benefit of a wider consumer population. Visit our newly launched website and read more here: https://lnkd.in/ed2QCx6Z

Twelve-month study published in Neuromodulation shows Altius? delivers significant and lasting pain reduction, decreases in opioid use, and improvements in quality of life for amputees suffering from debilitating chronic post-amputation pain. Link to the full article in our Press Release below: https://lnkd.in/gi7Y8Pfn

This morning, we shared positive results from the Phase 2 FORWARD-53 #Duchenne study, where we observed substantial dystrophin expression and a safe and well tolerated profile for WVE-N531. Learn more about these data and what’s next: https://lnkd.in/erzxGtSH

Neuros Medical Receives FDA Approval for the Altius? Direct Electrical Nerve Stimulation System The Altius? System represents a significant advancement in the treatment of chronic intractable post-amputation pain. Read more on PRNewswire: https://lnkd.in/gWN4cyVH

Cleveland is the city of many firsts: The first city to use electric streetlights. The first city to use electric traffic signals. And now, the first city to use a robot to paint crosswalks. That's thanks to RoadPrintz, a spinout company from Case School of Engineering at Case Western Reserve University, who are also tenants at the Sears think[box] at Case Western Reserve University Incubator. Read the article about their robot painting crosswalks in Public Square: https://lnkd.in/gX2cnVax